ViroCell Biologics
PrivateLast Round
Convertible Debt
Aug 14, 2024
Company Overview
ViroCell Biologics is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) focused on the design, optimization, and GMP manufacturing of lentiviral and retroviral vectors for cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViroCell Biologics Comparables
Compare ViroCell Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vector BioMed, Inc. | 93% | |
| Genezen | 89% | |
| VIVEbiotech | 89% |
ViroCell Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Aug 14, 2024 | ||||
| Seed | Apr 28, 2021 |
Key People
Founding team and executive leadership
ViroCell Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Disruptive Capital | Seed |
| Truell Conservation Foundation | Seed |
| First Light Asset Management | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 536% MoM, reaching 8.9K.
- Mar 24, 2025
Monthly visitors increased 42% MoM.
ViroCell Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ViroCell Biologics's valuation, stock price, and market status.
Is ViroCell Biologics a public or private company?
ViroCell Biologics is a private company.
What is the current stock price of ViroCell Biologics?
ViroCell Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is ViroCell Biologics worth (valuation)?
Valuation information for ViroCell Biologics is not publicly available.
Can I buy ViroCell Biologics stock?
ViroCell Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ViroCell Biologics's last funding round?
ViroCell Biologics's most recent funding round was Convertible Debt on August 14, 2024.
Who are the main investors in ViroCell Biologics?
Key investors in ViroCell Biologics include First Light Asset Management.
Will ViroCell Biologics IPO soon?
No public IPO plans have been announced for ViroCell Biologics.
How can I track ViroCell Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ViroCell Biologics's secondary market activity and sign up for updates.